|
1
|
Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.
|
Nature
|
2011
|
4.34
|
|
2
|
Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.
|
J Clin Invest
|
2011
|
4.21
|
|
3
|
Prohibitin-1 maintains the angiogenic capacity of endothelial cells by regulating mitochondrial function and senescence.
|
J Cell Biol
|
2008
|
1.56
|
|
4
|
MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion.
|
Nat Med
|
2013
|
1.34
|
|
5
|
The PLIN4 variant rs8887 modulates obesity related phenotypes in humans through creation of a novel miR-522 seed site.
|
PLoS One
|
2011
|
1.28
|
|
6
|
Statins promote the regression of atherosclerosis via activation of the CCR7-dependent emigration pathway in macrophages.
|
PLoS One
|
2011
|
1.25
|
|
7
|
Myoferlin regulates vascular endothelial growth factor receptor-2 stability and function.
|
J Biol Chem
|
2007
|
1.19
|
|
8
|
Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis.
|
FASEB J
|
2012
|
1.17
|
|
9
|
Phospholipase C beta3 deficiency leads to macrophage hypersensitivity to apoptotic induction and reduction of atherosclerosis in mice.
|
J Clin Invest
|
2008
|
1.09
|
|
10
|
Endothelial caveolin-1 regulates pathologic angiogenesis in a mouse model of colitis.
|
Gastroenterology
|
2008
|
1.04
|
|
11
|
Gain-of-function lipoprotein lipase variant rs13702 modulates lipid traits through disruption of a microRNA-410 seed site.
|
Am J Hum Genet
|
2012
|
1.01
|